Biotech

All Articles

Sanofi flunks MS study, inflicting yet another strike to Denali contract

.Sanofi has quit a period 2 ordeal of Denali Therapeutics-partnered oditrasertib in a number of scle...

Turnstone gives up 60%, shocks C-suite to extend money

.Turnstone Biologics is lessening its own headcount through 60% and agitating its own C-suite in ord...

Gilead gives up on $15M MASH wager after reviewing preclinical information

.In a year that has viewed an approval as well as a plethora of readouts for metabolic dysfunction-a...

Texas biotech axes cancer cells treaty, pins hopes on being overweight

.Alaunos Rehabs is axing an arrangement with Precigen, losing hope licensing civil rights to a custo...

Capricor reveals more records for DMD treatment after triggering BLA

.Capricor Therapeutics is taking a triumph tour for their phase 2 Duchenne muscular dystrophy (DMD) ...

FDA places Kezar lupus trial in grip following 4 person deaths

.The FDA has actually put Kezar Lifestyle Sciences' lupus trial on grip after the biotech flagged fo...

Phase 3 Intellectual Stone test hits SMA target, sending out stockpile 200%

.A stage 3 trial of Academic Stone's vertebral muscle degeneration (SMA) prospect has actually reach...

CAMP 4 is most recent to eye IPO, while Upstream point out $182M strategy

.RNA biotech CAMP4 Rehabs has marked out prepare for a $67 thousand IPO, with inflammation-focused U...

Galecto purchases leukemia medication, loses bone cancer cells property in pivot

.A year after the breakdown of an idiopathic lung fibrosis candidate delivered Galecto on a look for...

Judo tosses down $100M to knock senseless kidney condition

.Taking the floor covering is actually Judo Biography, an up-and-coming biotech equipped with $one h...